Company / Net Income
Bio-Rad Laboratories Net Income History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
$759.9M
FY2025
5-year range
-$3.6B / $4.3B
FY2021-FY2025
Trend
+141.2%
vs FY2024
Sector context
#31 of 164
Health Care
What the data says
Bio-Rad Laboratories's net income of $760M is higher than 81% of companies in the Health Care sector (FY2025). Net Income has fluctuated over the past 10 years, ranging from -$3.6B in FY2022 to $4.3B in FY2021.
Based on SEC 10-K filings.
$760M in FY2025 with a 5-year CAGR of +15.8%. Top quartile in the Health Care sector.
Improved from -$637M to $760M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- +15.8%
- 10-Year CAGR
- -
Sector benchmark
Top 19% in Health CareTop 19% of 164This company $759.9M Sector average $467.5M
▼
+62.5% above sector average
Key checks
Key Insights
- 5-year CAGR of +15.8%, indicating consistent growth.
- In FY2025, net income increased 141.2% year-over-year.
- Ranks #31 out of 164 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Strong return on equity: 23.0%
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $759.9M | +141.2% |
| FY2024 | -$1.8B | -189.4% |
| FY2023 | -$637.3M | +82.4% |
| FY2022 | -$3.6B | -185.3% |
| FY2021 | $4.3B | +1063.6% |
| FY2020 | $365.6M | -79.2% |
| FY2019 | $1.8B | +6664.1% |
| FY2018 | $26.0M | -76.2% |
| FY2017 | $109.2M | +23.0% |
| FY2016 | $88.8M | -18.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026